Instil Bio, Inc. Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
Instil Bio, Inc. (TIL) reported Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents of -$4.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Change in Cash
us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-13
- Instil Bio, Inc. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2026-03-31 was -$5.00K, a 111.63% decline year-over-year.
- Instil Bio, Inc. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2025-03-31 was $43.00K.
- Instil Bio, Inc. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2024-03-31 was -$63.00K.
- Instil Bio, Inc. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2023-03-31 was -$24.00K, a 103.29% decline year-over-year.
- Instil Bio, Inc. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2025 was $20.00K.
- Instil Bio, Inc. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2024 was -$94.00K.
- Instil Bio, Inc. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2023 was -$201.00K.
- Instil Bio, Inc. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2022 was -$637.00K.
| Period end | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 9 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$4.00K 10-Q · filed 2026-08-13 | |||
| 2026-03-31 | -$5.00K 10-Q · filed 2026-05-15 | |||
| 2025-12-31 | $20.00K 10-K · filed 2026-03-27 | |||
| 2025-09-30 | $39.00K 10-Q · filed 2025-11-13 | |||
| 2025-06-30 | $64.00K 10-Q · filed 2026-08-13 | |||
| 2025-03-31 | $43.00K 10-Q · filed 2026-05-15 | |||
| 2024-12-31 | -$94.00K 10-K · filed 2026-03-27 | |||
| 2024-09-30 | -$29.00K 10-Q · filed 2025-11-13 | |||
| 2024-06-30 | -$71.00K 10-Q · filed 2025-08-13 | |||
| 2024-03-31 | -$63.00K 10-Q · filed 2025-05-13 | |||
| 2023-12-31 | -$201.00K 10-K · filed 2025-03-04 | |||
| 2023-09-30 | -$182.00K 10-Q · filed 2024-11-13 | |||
| 2023-06-30 | -$97.00K 10-Q · filed 2024-08-13 | |||
| 2023-03-31 | -$24.00K 10-Q · filed 2024-05-10 | |||
| 2022-12-31 | -$637.00K 10-K · filed 2024-03-21 | |||
| 2022-09-30 | -$707.00K 10-Q · filed 2023-11-13 | |||
| 2022-06-30 | -$144.00K 10-Q · filed 2023-08-14 | |||
| 2022-03-31 | $729.00K 10-Q · filed 2023-05-11 | |||
| 2021-12-31 | -$304.00K 10-K · filed 2023-03-31 | |||
| 2021-09-30 | -$128.00K 10-Q · filed 2022-11-14 | |||
| 2021-06-30 | -$259.00K 10-Q · filed 2022-08-12 | |||
| 2021-03-31 | $78.00K 10-Q · filed 2022-05-16 | |||
| 2020-12-31 | $559.00K 10-K · filed 2022-03-07 | |||
| 2020-09-30 | $451.00K 10-Q · filed 2021-11-15 | |||
| 2020-06-30 | $194.00K 10-Q · filed 2021-08-12 | |||
| 2020-03-31 | $268.00K 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |